Send us Fan Mail

In Part 2, Ronny Szelinsky explains the mechanism behind oestrogen-driven microbiome collapse at menopause — and what can be done about it. He introduces the estrobolome, details the research behind Get Happy's Happy Fem probiotic formula, and explains why oral probiotics colonise the gynecological tract as effectively as vaginal delivery. This is the translational bridge between the science of Part 1 and the practical interventions of Part 3.

Key Topics

• How oestrogen controls the thickness of the vaginal and endometrial tissue, and what happens when it drops
• Why UTIs become suddenly frequent after menopause — the biological mechanism
• Vaginal dryness and pain during sex: the mucosal layer explained
• The estrobolome: the bacterial community around the ovaries and its proposed role in oestrogen production
• The contraceptive pill and its long-term impact on microbiome colonisation after stopping
• Happy Fem: how the product was developed, the research methodology, and the fertility clinic partnerships
• Why oral probiotics achieve equivalent vaginal colonisation to vaginal administration — three pathways
• Lactobacillus CA-15: what the published research shows
• Who should take vaginal probiotics and under what circumstances
• When to pause: during pregnancy, and why
• Dosing: six-month courses for specific goals; ongoing daily use for post-menopausal women

Timestamps

• [Part 2 start] — Hormone-microbiome axis, oestrogen and tissue thickness
• [~05:00 into part] — Why UTIs spike at menopause
• [~10:00] — The estrobolome: ovarian bacteria and oestrogen production
• [~17:00] — Happy Fem: product development and research methodology
• [~22:00] — Oral vs vaginal administration — clinical study results
• [~27:00] — Lactobacillus CA-15: what it does
• [~30:00] — Who should take it; when to pause; dosing logic

References and Resources

• Happy Fem product: www.get-happy.com
• Lactobacillus CA-15

Insta/TikTok: @BiohackingEve
Website: www.BiohackingEve.com